Alcohol 1992: Vol 9 Table of Contents

7 Pages·1992·1.6 MB·English

ALCOHOL
SUBJECT AND AUTHOR INDEX
VOLUME 9, 1992
Pergamon Press
New York ¢ Oxford ¢ Seoul * Tokyo
ALCOHOL
An International Biomedical Journal
incorporating Alcohol and Drug Research
Editor-in-Chief
R. D. MYERS
Department of Pharmacology, School of Medicine
East Carolina University, Greenville, NC 27858
Editorial Advisory Board
D. P. AGARWAL (Hamburg, Germany) K. KURIYAMA (Kyoto, Japan)
H. BEGLEITER (Brooklyn, NY) S. W. LESLIE (Austin, TX)
S. BORG (Stockholm, Sweden) M. LEWIS (Washington, DC)
A. C. COLLINS (Boulder, CO) T.-K. LI (Indianapolis, IN)
M. A. COLLINS (Maywood, IL) C. LIEBER (Bronx, NY)
J. C. CRABBE (Portland, OR) K. O. LINDROS (Helsinki, Finland)
C. K. ERICKSON (Austin, TX) N. MELLO (Belmont, MA)
C. J. P. ERIKSSON (Helsinki, Finland) D. R. PETERSON (Boulder, CO)
M. FAIMAN (Lawrence, KS) L. A.P OHORECKY (Piscataway, NJ)
J. FALK (New Brunswick, NJ) C. RANDALL (Charleston, SC)
G. FREUND (Gainesville, FL) E. RILEY (San Diego, CA)
D. GOLDSTEIN (Stanford, CA) H. H. SAMSON (Seattle, WA)
R. A. HARRIS (Denver, CO) J. D. SINCLAIR (Helsinki, Finland)
P. HOFFMAN (Denver, CO) B. TABAKOFF (Bethesda, MD)
W. A. HUNT (Rockville, MD) M. TRABUCCHI (Rome, Italy)
Y. ISRAEL (Toronto, Canada) D. H. VAN THIEL (Pittsburgh, PA)
H. KALANT (Toronto, Canada) D. W. WALKER (Gainesville, FL)
J. KHANNA (Toronto, Canada) M. J. WAYNER (San Antonio, TX)
K. KIIANMAA (Helsinki, Finland) J. R. WEST (Iowa City, IA)
Managing Editor:
M. A. MYERS
Editorial Offices:
R. D. MYERS
Department of Pharmacology, School of Medicine
East Carolina University, Greenville, NC 27858
Publishing, Subscription and Advertising Offices:
Pergamon Press Inc., 660 White Plains Road, Tarrytown, NY 10591-5153, USA, INTERNET “[email protected]”
and Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, England
Published Bimonthly
Annual institutional subscription rate (1993): £315 (US$599);
Personal subscription rate for those whose library subscribes at the regular rate (1993): £68 (US$129).
Sterling prices are definitive. US dollar prices are quoted for convenience only, and are subject to exchange rate fluctuation.
Prices include postage and insurance and are subject to change without notice.
VOLUME 9 1992
SUBJECT INDEX
AA and ANA rats, 369 Calcium-channel modulators, 293 8-OHDPAT, 283
AA rat line, 441 Capillarization, 473 Electron microscopy, 509
Aberrant drinking, 501 Carbachol, 63 Electrophysiology, 43
Absorption, 83 Cardiac function, 149 Emesis, 389
Acateldehyde, 207 Cardiorespiratory reflex, 317 Endothelial culture, 473
Acetaldehyde, 181, 535, 563 Cat, 389 Environmental cues, 327
Acetaldehyde-hemoglobin adducts, 563 Catalase, 207 Esophageal tumors, 465
Acetaldehyde-modified hemoglobin, 563 Catecholamines, 129 Essential metals, 241
Acetaldehyde oxidation, 375 Caudate-putamen, 23 Ethanol, 1, 9, 23, 31, 37, 43, 53, 63, 71, 83,
Acetate uptake, 541 Cell death, 171 87, 93, 95, 103, 109, 117, 129, 133, 167,
Action potential, 103 Ceramide molecular species, 323 185, 189, 193, 207, 241, 257, 271, 275,
Activation markers, 481 Cerebellum, 225, 261 279, 293, 327, 329, 355, 389, 403, 415,
Addiction, 327 C57BL/6 mice, 193 421, 433, 455, 459, 489, 495, 501, 513,
Adenosine, 541 C57 mice, 257 529, 541, 547, 559, 563
Aged rats, 299 Chick embryo, 161 Ethanol elimination, 213
Aging, 555 Chlordiazepoxide, 199 Ethanol-induced hepatocellular injury,
Alcohol, 9, 17, 37, 71, 139, 149, 171, 181, Choline acetyltransferase, 299 363
203, 213, 247, 299, 311, 381, 395, 415, Cholinergic neurons, 299 Ethanol intake, 53, 123, 375
445, 473, 541, 547, 555 Chronic alcoholism, 79 Ethanol metabolism, 139, 207
Alcohol abuse, 53 Chronic ethanol, 305 Ethanol preference, 283
Alcohol dehydrogenase, 421 Cimetidine, 363 Ethanol reinforcement, 409
Alcohol deprivation, 441 Citric acid, 155 Ethanol sensitivity, 261
Alcohol drinking, 49, 155, 441, 501, 547 Clofibrate, 139 Ethanol toxicity, 519
Alcohol preference, 501 Clofibrate analogues, 139 Excitatory amino acid receptor-operated
Alcohol selection, 123 Clonidine, 389 channels, 63
Alcchol sensitivity, 225 c-myc, 279
Alcoholic liver disease, 139, 341 Cocaine, 489 Fatty acid composition, 329
Alcoholic myopathym, 79 Concanavalin A, 489 Fatty liver, 93
Alcoholics, 49 Concurrent schedule, 547 Fetal alcohol exposure, 465, 481
Alcoholism, 53, 181, 233, 433, 501 Conditioned place preference, 1, 109, 185 Fetal alcohol syndrome, 37, 161, 171, 219,
Aldehyde dehydrogenase, 199 Conditioned taste aversion, 167 509
Aldehyde dehydrogenase inhibition, 349 Conduction velocity, 103 Fibrosis, 341
Alkanes and malondialdehyde due to etha- Context, 109 5-HT agonists, 523
nol iron chelator, 363 Continuous access, 409 5-HT-1A receptor agonists, 283
Alpha adrenoceptors, 389 Copper, 341 5-HT receptors, 369
a,-proteinase inhibitor, 181 Copper sulfate, 389 5-HT; receptors, 17
Alzheimer’s disease, 233 Corticosterone, 427, 465, 529 5-HT syndrome, 523
Angiotensin converting enzyme inhibitors, Crab, 103 Fixed-ratio schedule, 547
53 Cyanamide, 31, 349, 501, 563 Fluidity, 311
Angiotensin II, 53 Cytokine(s), 455, 489 Fluorescence polarization, 513
Anti-CD3 stimulation, 481 Cytoprotection, 421 Food deprivation, 547
Free intracellular Ca”* ,6 3
Antioxidant enzymes, 403
Area postrema, 389 Dentate gyrus, 271 Free radicals, 495
Ascorbate, 535 Development, 9 Free radical scavenger, 363
Atrial contraction, 293 Development of drinking, 501 Fura-2, 63
AAtvreirasli omne, mb1r09a ne potentials, 87 DDeixafzeenpfalmu,r am1i99n e, 559 GGAABBAAa,g , 51296 1
Diazepam-insensitive binding, 261
GABA-benzodiazepine, 233
BBBeeeehhraa,vv ii9oo rraall treoalcetriavnictey,, 512673 DDDiiihmayezdterhpoyaplmy rsisudelinfsnoiextsii,dve i,ty2 ,95 31 232 5 GGGaaAlnBagclAti,ooss ei,dr eecs8e,3p to3r2s3, 225
Benzodiazepine receptors, 261 Diphenylhexatriene, 513 Gastric fistula, 75
Benzodiazepines, 199 Diphenylhexatriene propionic acid, 513 Gastric infusion model, 473
8-adrenoceptors, 305 Disulfiram, 199 Gastric injury, 421
Dopamine, 17
BB-iepshtarsaidci ole,f fe4c6t5s , 117 Dopamine-D, receptors, 355 GGeCn/dMeSr,, 33111 , 421
Blood alcohol level, 75 Dopamine release, 23 Gender differences, 193, 257
Drug discrimination, 1, 71, 117
Blood circulation, 149 Genetic factors, 501
Blood ethanol levels, 547 Drug history, 1 Genetic lines, 155
Bombesin, 123 Drug metabolism, 139 Glucocorticoid cytosolic receptor, 481
Drug reinforcement, 547
Brain damage, chronic, 233 Glucose, 9
Drug testing, 441
Brain temperature, 275 Glutamate receptors, 37
D2-dopamine receptors, 133
Breath acetaldehyde, 189 Glutathione, 241
Breath ethanol, 189 EEG, 275 Granule cells, 225
Buspirone, 283 Eicosanoids, 139 Gustatory reactions, 155
574
HAD, 71 Motor activity, 207 Receptors, 233
HAS, 117 Motor axon, 103 Receptors, muscarinic, 233
3H-DA, 23 Murine AIDS, 495 Red blood cells, 563
Heart, 305, 329 Muscarinic cholinoceptors, 389 Regeneration, 279
Heat tolerance, 129 Muscle protein, 79 Renal ultrastructure, 509
Hematopoietic variables, 241 Muscle RNA, 79 Response compatibility, 445
Hemodynamics, 149 Myocardium, 293 Restraint, 427
Hemoglobin, 563 Reward, 109
Heparegen, 403 NDO-008, 283 Rhesus monkeys, 547
[H]5-HT, 369 Nebulization of acetaldehyde, 317 Richter tubes, 441
Hippocampus, 37 Neonatal dissociated brain cells, 63 Ro 15-4513, 193
PH] ketanserin, 369 Nerve growth factor, 171, 299
(PH)LY278584, 369 Neurons, 541 Saccharin, 155, 203
[PH)Ro 15-4513, 261 Neurotensin, 23 Salsolinol, 49
[PH]Ro 15-4513 binding, 225 Neurotrophic factors, 161 Salt, 155
Human serum, 181 NGF, 161 Scentmaking, 287
(PH]-YM-09151-2 binding, 133 N-hydroxycyanamide, 349 Selected rat lines, 225, 261
Hyperresponsiveness to stress, 219 Nicotine, 87 Selective breeding, 71, 369
Hypertension, 139 Nigrostriatal tract, 355 Self-administration, 1
Hypoglycemia, 9 Nitroxyl, 349 Sensitization, 327
N-methyl-D-aspartate, 555 Serotonin, 17, 559
Imidazole-preferring sites, 389 N-methyl-D-aspartate receptors, 37 Sex difference(s), 219, 415
Immune defects, 455 Norepinephrine, 389 Sexual dimorphism, 287
Immunity, 459 Novelty, 427 Sexual maturation, 501
In vivo, 541 Nucleus accumbens, 17, 23 SH group, 403
In vivo release, 17 Nutritive expectancy, 123 Sham ingestion, 75
In vivo voltammetry, 535 Sinuosoid, 473
Infectious diseases, 459 Olfaction, 247 Sleep, 275
Inhibition, 389 i1-methyl-1,2,3,4-tetrahydro-6-car- Sleep deprivation, 445
Inotropism, 293 boline-3-carboxylic acid, 31 Sleep-time, 71
Intermittent alcoholization, 311 Operant behavior, 109, 193 Somatosensory-evoked potentials, 43
Intracerebroventicular injection, 389 Opiates, 155 Sphingoid base, 323
Iron, 341 Opioids, 433 Spontaneous hypertensive rats (SHR), 139
Oral drug intake, 203 Spontaneous motor activity, 185
Kainate, 63 Oral drug self-administration, 547 Steatosis, 341
Labeling index, 95 Palatability, 381 Steroid hormones, 95
LAD, 71 Pancreatitis, 181 Stimulus evaluation, 445
LAS, 117 Pattern of drinking, 415 Stimulus intensity, 445
Lead, 241 Pheochromocytoma (PC12) cells, 171 Stimulus properties of drugs, 71
Learning, 75 Pituitary-adrenal system, 219 Stimulus quality, 445
Lick rate, 381 Placenta, 395 Stress, 219, 529
Lifetime prolongation, 139 Plasma glycerol, 93 Striatum, 133
Lighting cycle, 123 P/NP rats, 185 Synaptic membrane, 311
Limited access, 441 Postingestive factors, 75 Synaptic plasma membranes, 513
Limited access procedure, 123 P rat, 559 Synaptosomes, 323
Lipid peroxidation, 241, 329 Predictable stress, 427 Taste, 155
Lipoperoxidation, 363 Preferences, 381 Taste preference, 203
Lisinopril, 53 Prenatal alcohol, 523 Taste reactivity, 381
Liver, 139, 279 Prenatal ethanol, 287 Terminal vessels, 271
Liver histomorphometry, 341 Prenatal ethanol exposure, 427 Thymocyte, 481
Locomotor activity, 257 Prenatal ethanol treatment, 161 Time-course, 185
LS and SS mice, 323 Preoptic area, 275 Tolerance, 109, 311
Lymph, 473 Progesterone, 395 Trimethylammonium-diphenylhexatriene,
Magnetic resonance imaging, 247 Prolactin, 465 513
Malnutrition, 341 Prolactinoma, 465 Trypsin, 181
Mammary gland, 95 Prostaglandins, 139, 421 Tryptophan, 31
Manganese, 341 Protein deficiency, 341 Tumor, 495
Protooncogene, 279
Markers for ethanol intake, 189
MDA, 403 Psychological stressors, 427 Unpredictable stress, 427
Pulmonary artery, 149 UPSIT, 247
Membrane fluidity, 513
Pulmonary J receptors, 317 Urinary salsolinol, 49
Mesolimbic tract, 355
Pulmonary pressure, 149
Methodology, 441
Pyridoxine, 519 Vitamin E, 329
Mice, 529
Voltage-dependent CA?* channels, 63
Mice strains, 287 Quinine, 155 Voluntary alcohol consumption, 139, 369
Microcirculation, 473 Quisqualate, 63
Microdialysis, 17 Warm acclimation, 129
Microinjection, 275 Race, 213 Water intake, 123
Mitochondrial function, 375 Rat(s), 53, 117, 139, 219, 275, 283, 311, Whole intestine, 83
Mitogen proliferative response, 481 381, 403, 409, 421, 433, 509, 535 Withdrawal, 43, 355
Morphine, 433 Rat brain, 31
Morphometry, 271 Reaction time, 445 Zinc, 341
AUTHOR INDEX
Abi-Dargham, A., 369 Elder, N. B., 381 Koalick, F., 49 Phillis, J. W., 541
Abril, E. R., 455 Engel, J. A., 535 Korpi, E. R., 225, 261, 369 Pilati, M. L., 481
Adeyiga, O., 395 Erwin, V. G., 23 Kostowski, W., 283 Piotrowski, J. J., 329
Ahluwalia, B., 395 Eskelson, C. D., 329, 495 Krahn, D. D., 203 Pirozhkov, S. V., 329, 489
Akane, A., 31 Kraszpulski, M., 271 Pohorecky, L. A., 305
Akbasak, B., 395 Falk, S., 139 Krimmer, E. C., 71 Ponticiello, R., 305
Aloe, L., 299 Farbiszewski, B., 403 Krdossin, A., 139 Potter, J. D., 563
Amit, Z., 207 Feest, U., 49 Krull, K. R., 445 Prasad, C., 133
Andrews, C. M., 409, 433 Files, F. J., 409 Kulkosky, P. J., 123
Aragon, C. M. G., 207 Flora, S. J. S., 241 Kwon, C.-H., 349 Queen, S. A., 37
Assadi, F. K., 509 Frackelton, W. F., 257 Quintanilla, M. E., 375
Freund, G., 233 Lancaster, F. E., 9, 415
Badger, T. M., 279 Fukuishima, S., 31 Lands, W. E. M., 327 Rabe, H., 49
Baker, R. C., 323 Fulginiti, S., 523 Laruelle, M., 36° Radecka, A., 403
Ballinger, Jr., W. E., 233 Lee, M. J. C., 349 Radulovacki, 275
Bao, K., 193 Galindo-Martin, L., 341 Lee, L., 421 Raeder, C., 355
Barnett, M., 75 Gallardo-Carpentier, A., 87, Lekovic, G., 275 Rajguru, S., 395
Barwick, V.S., 501 293 Leslie, S. W., 63, 555 Ramirez, Jr., G., 473
Beaugé, F., 311 Gapstur, S. M., 563 Lewis, R. S., 433 Randall, C. L., 287
Becker, H. C., 193, 287 Gauvin, D. V., 1, 109, 167 Li, T.-K., 17, 155 Ray, R., 199
Bedingfield, J. B., 109 Gonzales, R. A., 555 Lukaszyk, I., 271 Reid, L. D., 53
Belcher, J. D., 563 Gonzalez, L. E., 519 Lumeng, L., 17 Rodriguez-Moreno, F., 341
Beleslin, D. B., 389 Gonzalez, L. P., 43 Lumpkin, Jr., C. K., 279 Rommelspacher, H., 355
Berkowitz, A. S., 465 Gonzalez-Reimers, E., 341 Luo, J., 171 Rowland, N. E., 75, 559
Bernas, M. J., 473 Goodlett, C. R., 37, 171 Rubio, J. M., 83
Bernhard, V., 329 Gosnell, B. A., 203 Macenski, M. J., 547 Rudzinska-Kisiel, T., 271
Bice, P. J., 381 Gottesfeld, Z., 453, 465 Machu, T., 63
Bilsky, E. J., 53 Gross, M. D., 563 Mahoney, J. C., 37 Saad, A. J., 459
Bogart, C. J., 43 Guru, S. C., 199 Marrinan, D. A., 123 Salvatici, R. P., 293
Boggan, W. O., 257 Martinez, F., 455 SamardiZi¢, R., 389
Borgs, P., 473 Hale, R. L., 287 Martinez-Riera, A., 341 Samson, H. H., 409, 433
Brecher, A. S., 181 Hamdi, A., 133 Matsubara, K., 31 Sanchez, C. F., 37
Brown, L. M., 555 Hamm, M.., 305 McBride, W. J., 17 Sanchez, M. R., 123
Brugére, S. S., 317 Hayden, J. B., 279 McClung, J. K., 279 Santolaria-Fernandez, F., 341
Briining, G., 355 Heaton, M. B., 161 McGivern, R. F., 335 Sarviharju, M., 225
Butters, N., 247 Held, I. R., 79 McNary, M. Q., 95 Saukko, P., 149
Henagan, J. M., 421 McNeill, D. L., 43 Savage, D. D., 37
Carpentier, G., 293 Hernandez, L., 519 Meisch, R. A., 547 Schechter, M. D., 71, 117,
Carpentier, R. G., 87 Hilakivi, L. A., 369 Middaugh, L. D., 193, 287, 185
Carreras, O., 83 Hodge, C. W., 433 257 Schlicht, I., 139
Carryl, O. R., 87 Holloway, F. A., 1, 109, 167 Miller, T. A., 421 Schmidt, K. L., 421
Carter, E. A., 93 Holownia, A., 403 Minetti, S. A., 523 Schuckit, M. A., 247
Castre, E., 225 Honkanen, A., 369 Mohnhaupt, A., 139 Schwarz-Stevens, K., 409
Castro-Aleman, V.,341 Hubbell, C. L., 53 Morian, K. R., 559 Segal, B., 213
Cermak, L. S., 247 Hunt, W. A., 327 Mrak, R. E., 513 Seppala, T., 225
Channabasavanna, S. M., Hunter, G. C., 329 Mufti, S. J., 495 Shaw, S., 363
199 Huttunen, P., 129 Murillo, M. L., 83 Shear, P. K., 247
Chaudhury, H., 305 Hyytia, P., 441 Murthy, P., 199 Shepherd, C. L., 193, 257
Chen, G.-J., 489 Myers, R. D., 501 Shiono, H., 31
Chiappelli, F., 481 Irwin, M., 247 Shirota, F. N., 349
Chrisbacher, G. A., 53 Isaacson, R. L., 293 Nagasawa, H. T., 349 Sinclair, J. D., 155, 441
Chwiecko, M., 403 Nickel, B., 49 Singletary, K. W., 95
Conde-Martel, A., 341 Japundzié, N., 389 Nikolic, S. B., 389 Smith, D., 395
Corrales, J., 317 Jayatilleke, E., 363 Nurmi, M., 441 Smith, L. T., 445
Crabbe, J. C., 529 Jernigan, T. L., 247 Spiegel, K. S., 9, 415
Jerrells, T. R., 459 Odeleye, O. E., 495 Stephens,P. J., 103
Deitrich, R. A., 323 Johannessen, K., 535 Onofrio, A., 257 Stewart, R., 155
Delgado, M. J., 83 Jones, T. W., 555 O’Regan, M. H., 541 Stojanovic, M., 275
DeMaster, E. G., 349, 563 Jovanovié-Mi¢ié, D., 389 Suzdak, P. D., 225
Dhawan, M., 241 Paiva, M., 161 Svensson, L., 535
Dildy-Mayfield, J. E., 63 Kalbfleisch, L. D., 445 Paivarinta, P., 369 Swanson, D. J., 161
DiTraglia, G. M., 247 Kampov-Polevoy, A., 155 Pantazis, N. J., 171
Dohrman, D. P., 171 Kaulen, P., 355 Parada, M. A., 519 Tampier, L., 375
Domiati-Saad, R., 459 Keith, L. D., 529 Parsons, O. A., 445 Tandon, S. K., 241
Draski, L. J., 323 Kemper, A., 49 Pavlock, J. L., 181 Taranath Shetty, K., 199
Duffy, L. K., 213 Kettunen, R., 149 Paxton, L. L., 37 Tarpley, M. D., 279
Duncan, C. C., 23 Keyes Scott, B., 189 Penna, M. A., 317 Taylor, A. N., 481
Dyr, W., 283 Kiefer, S. W., 381 Perkins, L. M., 541 Taylor, J. M., 279
King, D. A., 109 Pesold, C. N., 207 Ticho, S. R., 275
Earnest, D. L., 455 Knapp, D. J., 305 Peterson, M., 189 Timisjarvi, J., 149
576
Tio, D., 481 Ullman, M. D., 323 Watson, R. R., 329, 453, 455, Wrzolkowa, T., 271
Tirassa, P., 299 Uusi-Oukari, M., 225, 261 489, 495 Wu, C., 535
Tolliver, G. A., 409 Way, D. L., 473
Tornwall, M. S., 421 Vazquez, A. L., 83 Weinberg, J., 219, 427 Yellon, S. M., 335
Trent, R. D., 555 Ventura, R. F., 323 West, J. R., 37, 171 Yoshimoto, K., 17
Trippe, K., 465 Vigliecca, N. S., 523 White, M. H., 473
Tritt, S. H., 481 Witte, C. L., 473 Zajac, C. S., 509
Tuominen, K., 369 Walker, D. W., 161 Wong, M. K. C., 189 Zerouga, M., 311
Tuominen, T., 225 Wargovich, M. J., 465